Related Experiment Video
Updated: Aug 6, 2026

Randomized Controlled Trial to Study the Acute Effects of Strength Exercise on Insulin Sensitivity in Obese Adults
Published on: December 1, 2023
Longitudinal changes in insulin-like growth factor-I, insulin sensitivity, and secretion from birth to age three
Germán Iñiguez1, Ken Ong, Rodrigo Bazaes
1Institute of Maternal and Child Research, Faculty of Medicine, University of Chile, 1027 Santiago, Chile.
Insights
Insulin resistance in small for gestational age (SGA) infants is linked to higher IGF-I levels by age 3. These levels correlate with weight, BMI, and insulin resistance, suggesting potential IGF-I resistance in SGA infants post-catch-up growth.
Area of Science:
- Pediatric endocrinology
- Growth and development studies
- Metabolic health research
Background:
- Insulin resistance (IR) is observed in small for gestational age (SGA) infants with rapid postnatal weight gain.
- Infancy height gains correlate with increased insulin secretion.
- The relationship between IGF-I, growth parameters, and metabolic markers in SGA infants requires further elucidation.
Purpose of the Study:
- To investigate the differential associations of Insulin-like Growth Factor I (IGF-I) levels with linear growth (length) and weight gain.
- To examine the relationship between IGF-I levels and both insulin secretion and insulin resistance (IR) in SGA infants.
Main Methods:
- A prospective study involving 50 SGA and 14 appropriate for gestational age (AGA) newborns.
- Serum IGF-I levels measured at birth, 1 year, and 3 years.
- Insulin resistance (IR) assessed using homeostasis model assessment and insulin secretion via short intravenous glucose tolerance tests at 1 and 3 years.
Main Results:
- SGA infants exhibited lower birth IGF-I but higher 3-year IGF-I levels compared to AGA infants.
- At 1 year, IGF-I in SGA infants correlated with length gain and insulin secretion.
- By 3 years, IGF-I in SGA infants was positively associated with weight, body mass index (BMI), and IR.
Conclusions:
- IGF-I levels demonstrated rapid postnatal increase in SGA infants, unlike AGA infants.
- During the first year, IGF-I related to beta-cell function and linear growth.
- By 3 years, elevated IGF-I in SGA infants correlated with BMI and IR, suggesting possible relative IGF-I resistance after catch-up growth completion.
Introduction:
Insulin resistance (IR) develops as early as age 1 to 3 yr in small for gestational age (SGA) infants who show rapid catch-up postnatal weight gain. In contrast, greater insulin secretion is related to infancy height gains. We hypothesized that IGF-I levels could be differentially related to gains in length and weight and also differentially related to IR and insulin secretion.
Methods:
In a prospective study of 50 SGA (birth weight < 5th percentile) and 14 normal birth weight [appropriate for gestational age (AGA)] newborns, we measured serum IGF-I levels at birth, 1 yr, and 3 yr. IR (by homeostasis model assessment) and insulin secretion (by short iv glucose tolerance test) were also measured at 1 yr and 3 yr.
Results:
SGA infants had similar mean length and weight at 3 yr compared with AGA infants. SGA infants had lower IGF-I levels at birth (P < 0.0001), but conversely they had higher IGF-I levels at 3 yr (P = 0.003) than AGA infants. Within the SGA group, at 1 yr IGF-I was associated with length gain from birth and insulin secretion (P < 0.0001); in contrast at 3 yr IGF-I was positively related to weight, body mass index, and IR.
Conclusions:
IGF-I levels increased rapidly from birth in SGA, but not AGA children. During the key first-year growth period, IGF-I levels were related to beta-cell function and longitudinal growth. In contrast, by 3 yr, when catch-up growth was completed, IGF-I levels were related to body mass index and IR, and these higher IGF-I levels in SGA infants might indicate the presence of relative IGF-I resistance.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Longitudinal Research
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Nature and Nurture
Type I Diabetes III: Clinical Manifestations
